Podcast: Meet our researchers
Webinar
Join our webinar The ethics, safety and justification for evaluating hydroxychloroquine and chloroquine to prevent COVID-19 (download pdf), on Tuesday, 26 January 2021 at 10:00 New York | 12:00 São Paolo | 16:00 Geneva | 20:30 Delhi | 22:00 Bangkok. Register
copcov study
Needed: Healthcare staff for the #COPCOV drug trial to prevent COVID-19.
There is increasing evidence that hydroxychloroquine has some preventive COVID-19 benefit. COPCOV is the world’s largest trial trying to determine: Can hydroxychloroquine help prevent COVID-19 in healthcare workers? To enrol in the UK, visit the COPCOV registration site.
What's new
Susie Dunachie awarded flagship NIHR career development award
16 December 2020
Clare Ling awarded honorary FRCPath
23 November 2020
Latest publications
-
Probabilistic transmission models incorporating sequencing data for healthcare-associated Clostridioides difficile outperform heuristic rules and identify strain-specific differences in transmission
Journal article
Eyre DW. et al, (2021), PLOS Computational Biology, 17, e1008417 - e1008417
-
Optimal design for phase 2 studies of SARS-CoV-2 antiviral drugs
Journal article
Watson JA. et al, (2021)
-
Detection and differentiation of Burkholderia species with pathogenic potential in environmental soil samples.
Journal article
Janesomboon S. et al, (2021), PloS one, 16